Profound Medical Corp.
NCM: PROFLive Quote
📈 ZcoreAI Score
Our AI model analyzes Profound Medical Corp.'s price action across multiple timeframes using regression channels and statistical scoring.
Get PROF Z-Score →About Profound Medical Corp.
Healthcare
Medical Devices
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
📊 Fundamental Analysis
Profound Medical Corp. demonstrates a profit margin of -264.4%, which is below the sector average, suggesting competitive pressure.
The company recently reported 43.1% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -67.1%, which indicates that capital utilization is currently under pressure.
At a current price of $5.95, PROF currently sits at the 42nd percentile of its 52-week range (Range: $3.76 - $8.95).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$215.95M
Trailing P/E
--
Forward P/E
-7.59
Beta (5Y)
0.47
52W High
$8.95
52W Low
$3.76
Avg Volume
237K
Day High
Day Low